Gunar Zagars

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Activities & Behaviors

Actuarial Analysis

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Guadagnolo B Ashleigh; Zagars Gunar K; Raymond A Kevin; Benjamin Robert S; Sturgis Erich M
Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment.
Guadagnolo B Ashleigh; Zagars Gunar K
Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma.
Beadle Beth M; Guadagnolo B Ashleigh; Ballo Matthew T; Lee Jeffrey E; Gershenwald Jeffrey E; Cormier Janice N; Mansfield Paul F; Ross Merrick I; Zagars Gunar K
Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gunar Zagars (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Guadagnolo B Ashleigh; Zagars Gunar K; Raymond A Kevin; Benjamin Robert S; Sturgis Erich M
Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment.
Cancer 2009;115(14):3262-70.
2009: Guadagnolo B Ashleigh; Zagars Gunar K
Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma.
The lancet oncology 2009;10(4):409-16.
2009: Beadle Beth M; Guadagnolo B Ashleigh; Ballo Matthew T; Lee Jeffrey E; Gershenwald Jeffrey E; Cormier Janice N; Mansfield Paul F; Ross Merrick I; Zagars Gunar K
Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
International journal of radiation oncology, biology, physics 2009;73(5):1376-82.
2008: Guadagnolo B Ashleigh; Zagars Gunar K; Ballo Matthew T; Strom Sara S; Pollock Raphael E; Benjamin Robert S
Mortality after cure of soft-tissue sarcoma treated with conservation surgery and radiotherapy.
Cancer 2008;113(2):411-8.
2008: Guadagnolo B Ashleigh; Zagars Gunar K; Ballo Matthew T
Long-term outcomes for desmoid tumors treated with radiation therapy.
International journal of radiation oncology, biology, physics 2008;71(2):441-7.
2008: Guadagnolo B Ashleigh; Zagars Gunar K; Ballo Matthew T; Patel Shreyaskumar R; Lewis Valerae O; Benjamin Robert S; Pollock Raphael E
Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy.
International journal of radiation oncology, biology, physics 2008;70(3):760-5.
2007: Guadagnolo B Ashleigh; Zagars Gunar K; Ballo Matthew T; Patel Shreyaskumar R; Lewis Valerae O; Pisters Peter W T; Benjamin Robert S; Pollock Raphael E
Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy.
International journal of radiation oncology, biology, physics 2007;69(4):1173-80.
2007: Pisters Peter W T; Pollock Raphael E; Lewis Valerae O; Yasko Alan W; Cormier Janice N; Respondek Paula M; Feig Barry W; Hunt Kelly K; Lin Patrick P; Zagars Gunar; Wei Caimiao; Ballo Matthew T
Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas.
Annals of surgery 2007;246(4):675-81; discussion 681-2.
2007: Lev Dina; Kotilingam Dhanasekaran; Wei Caimiao; Ballo Matthew T; Zagars Gunar K; Pisters Peter W T; Lazar Alexander A; Patel Shreyaskumar R; Benjamin Robert S; Pollock Raphael E
Optimizing treatment of desmoid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1785-91.
2007: Torres Mylin A; Ballo Matthew T; Butler Charles E; Feig Barry W; Cormier Janice N; Lewis Valerae O; Pollock Raphael E; Pisters Peter W; Zagars Gunar K
Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy.
International journal of radiation oncology, biology, physics 2007;67(4):1124-9.
2007: Lin Patrick P; Pino Eduardo Diaz; Normand Anne N; Deavers Michael T; Cannon Christopher P; Ballo Matthew T; Pisters Peter W T; Pollock Raphael E; Lewis Valerae O; Zagars Gunar K; Yasko Alan W
Periosteal margin in soft-tissue sarcoma.
Cancer 2007;109(3):598-602.
2007: Ballo Matthew T; Zagars Gunar K; Pollock Raphael E; Benjamin Robert S; Feig Barry W; Cormier Janice N; Hunt Kelly K; Patel Shreyaskumar R; Trent Jonathan C; Beddar Sam; Pisters Peter W T
Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment.
International journal of radiation oncology, biology, physics 2007;67(1):158-63.
2006: Cannon Christopher P; Ballo Matthew T; Zagars Gunar K; Mirza Attiqa N; Lin Patrick P; Lewis Valerae O; Yasko Alan W; Benjamin Robert S; Pisters Peter W T
Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas.
Cancer 2006;107(10):2455-61.
2006: Tseng Jennifer F; Ballo Matthew T; Langstein Howard N; Wayne Jeffrey D; Cormier Janice N; Hunt Kelly K; Feig Barry W; Yasko Alan W; Lewis Valerae O; Lin Patrick P; Cannon Christopher P; Zagars Gunar K; Pollock Raphael E; Pisters Peter W T
The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas.
Annals of surgical oncology 2006;13(9):1209-15.
2006: Ballo Matthew T; Ross Merrick I; Cormier Janice N; Myers Jeffrey N; Lee Jeffrey E; Gershenwald Jeffrey E; Hwu Patrick; Zagars Gunar K
Combined-modality therapy for patients with regional nodal metastases from melanoma.
International journal of radiation oncology, biology, physics 2006;64(1):106-13.
2004: Ballo Matthew T; Zagars Gunar K; Gershenwald Jeffrey E; Lee Jeffrey E; Mansfield Paul F; Kim Kevin B; Camacho Luis H; Hwu Patrick; Ross Merrick I
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Annals of surgical oncology 2004;11(12):1079-84.
2004: Pisters Peter W T; Patel Shreyaskumar R; Prieto Victor G; Thall Peter F; Lewis Valerae O; Feig Barry W; Hunt Kelly K; Yasko Alan W; Lin Patrick P; Jacobson Marc G; Burgess Michael A; Pollock Raphael E; Zagars Gunar K; Benjamin Robert S; Ballo Matthew T
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(16):3375-80.
2004: Ballo Matthew T; Zagars Gunar K; Cormier Janice N; Hunt Kelly K; Feig Barry W; Patel Shreyaskumar R; Pisters Peter W T
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma.
International journal of radiation oncology, biology, physics 2004;58(5):1461-7.
2004: Zagars Gunar K; Ballo Matthew T; Lee Andrew K; Strom Sara S
Mortality after cure of testicular seminoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):640-7.
2003: Zagars Gunar K; Ballo Matthew T; Pisters Peter W T; Pollock Raphael E; Patel Shreyaskumar R; Benjamin Robert S
Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy.
International journal of radiation oncology, biology, physics 2003;57(3):739-47.
2003: Little Darren J; Kuban Deborah A; Levy Lawrence B; Zagars Gunar K; Pollack Alan
Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study.
Urology 2003;62(4):707-13.
2003: Caudell Jimmy J; Ballo Matthew T; Zagars Gunar K; Lewis Valerae O; Weber Kristin L; Lin Patrick P; Marco Rex A; El-Naggar Adel K; Benjamin Robert S; Yasko Alan W
Radiotherapy in the management of giant cell tumor of bone.
International journal of radiation oncology, biology, physics 2003;57(1):158-65.
2003: Pisters Peter W T; Ballo Matthew T; Fenstermacher Mark J; Feig Barry W; Hunt Kelly K; Raymond Kevin A; Burgess Michael A; Zagars Gunar K; Pollock Raphael E; Benjamin Robert S; Patel Shreyaskumar R
Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3092-7.
2003: Patel Shreyaskumar R; Zagars Gunar K; Pisters Peter W T
The follow-up of adult soft-tissue sarcomas.
Seminars in oncology 2003;30(3):413-6.
2003: Zagars Gunar K; Ballo Matthew T; Pisters Peter W T; Pollock Raphael E; Patel Shreyaskumar R; Benjamin Robert S
Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome.
International journal of radiation oncology, biology, physics 2003;56(2):482-8.
2003: Zagars Gunar K; Ballo Matthew T
Significance of dose in postoperative radiotherapy for soft tissue sarcoma.
International journal of radiation oncology, biology, physics 2003;56(2):473-81.
2003: Zagars Gunar K; Ballo Matthew T; Pisters Peter W T; Pollock Raphael E; Patel Shreyaskumar R; Benjamin Robert S
Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy.
Cancer 2003;97(10):2544-53.
2003: Zagars Gunar K; Ballo Matthew T; Pisters Peter W T; Pollock Raphael E; Patel Shreyaskumar R; Benjamin Robert S; Evans Harry L
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Cancer 2003;97(10):2530-43.
2003: Zagars Gunar K; Ballo Matthew T
Sequencing radiotherapy for soft tissue sarcoma when re-resection is planned.
International journal of radiation oncology, biology, physics 2003;56(1):21-7.
2003: Ballo Matthew T; Zagars Gunar K
Radiation therapy for soft tissue sarcoma.
Surgical oncology clinics of North America 2003;12(2):449-67, vii.
2003: Ballo Matthew T; Bonnen Mark D; Garden Adam S; Myers Jeffrey N; Gershenwald Jeffrey E; Zagars Gunar K; Schechter Naomi R; Morrison William H; Ross Merrick I; Kian Ang K
Adjuvant irradiation for cervical lymph node metastases from melanoma.
Cancer 2003;97(7):1789-96.
2003: Pollack Alan; Cowen Didier; Troncoso Patricia; Zagars Gunar K; von Eschenbach Andrew C; Meistrich Marvin L; McDonnell Timothy
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x.
Cancer 2003;97(7):1630-8.
2002: Ballo Matthew T; Gershenwald Jeffrey E; Zagars Gunar K; Lee Jeffrey E; Mansfield Paul F; Strom Eric A; Bedikian Agop Y; Kim Kevin B S; Papadopoulos Nicholas E; Prieto Victor G; Ross Merrick I
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4555-8.
2002: Pollack Alan; Zagars Gunar K; Antolak John A; Kuban Deborah A; Rosen Isaac I
Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.
International journal of radiation oncology, biology, physics 2002;54(3):677-85.
2002: Pollack Alan; Kuban Deborah A; Zagars Gunar K
Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer.
Urology 2002;60(3 Suppl 1):22-30; discussion 30-1.
2002: Lin Patrick P; Guzel Volkan B; Pisters Peter W T; Zagars Gunar K; Weber Kristin L; Feig Barry W; Pollock Raphael E; Yasko Alan W
Surgical management of soft tissue sarcomas of the hand and foot.
Cancer 2002;95(4):852-61.
2002: Pollack Alan; Zagars Gunar K; Starkschall George; Antolak John A; Lee J Jack; Huang Eugene; von Eschenbach Andrew C; Kuban Deborah A; Rosen Isaac
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.
International journal of radiation oncology, biology, physics 2002;53(5):1097-105.
2002: Little Darren J; Ballo Matthew T; Zagars Gunar K; Pisters Peter W T; Patel Shreyaskumar R; El-Naggar Adel K; Garden Adam S; Benjamin Robert S
Adult rhabdomyosarcoma: outcome following multimodality treatment.
Cancer 2002;95(2):377-88.
2002: Cowen Didier; Troncoso Patricia; Khoo Vincent S; Zagars Gunar K; von Eschenbach Andrew C; Meistrich Marvin L; Pollack Alan
Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1148-54.
2002: Ballo Matthew T; Strom Eric A; Zagars Gunar K; Bedikian Agop Y; Prieto Victor G; Mansfield Paul F; Lee Jeffrey E; Gershenwald Jeffrey E; Ross Merrick I
Adjuvant irradiation for axillary metastases from malignant melanoma.
International journal of radiation oncology, biology, physics 2002;52(4):964-72.
2002: Ahmad Syed A; Patel Shreyaskumar R; Ballo Matthew T; Baker Treneth P; Yasko Alan W; Wang Xuemei; Feig Barry W; Hunt Kelly K; Lin Patrick P; Weber Kristen L; Chen Lei L; Zagars Gunar K; Pollock Raphael E; Benjamin Robert S; Pisters Peter W T
Extraosseous osteosarcoma: response to treatment and long-term outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):521-7.
2001: Zagars G K; Pollack A
Radiotherapy for stage II testicular seminoma.
International journal of radiation oncology, biology, physics 2001;51(3):643-9.
2001: Callister M D; Ballo M T; Pisters P W; Patel S R; Feig B W; Pollock R E; Benjamin R S; Zagars G K
Epithelioid sarcoma: results of conservative surgery and radiotherapy.
International journal of radiation oncology, biology, physics 2001;51(2):384-91.
2001: Ballo M T; Zagars G K; Pisters P W; Feig B W; Patel S R; von Eschenbach A C
Spermatic cord sarcoma: outcome, patterns of failure and management.
The Journal of urology 2001;166(4):1306-10.
2001: Cormier J N; Patel S R; Herzog C E; Ballo M T; Burgess M A; Feig B W; Hunt K K; Raney R B; Zagars G K; Benjamin R S; Pisters P W
Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma.
Cancer 2001;92(6):1550-5.
2001: Zagars G K; Pollack A; von Eschenbach A C
Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer.
Urology 2001;58(2):233-9.
2000: Pollack A; Zagars G K; Smith L G; Lee J J; von Eschenbach A C; Antolak J A; Starkschall G; Rosen I
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(23):3904-11.
2000: Storey M R; Pollack A; Zagars G; Smith L; Antolak J; Rosen I
Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial.
International journal of radiation oncology, biology, physics 2000;48(3):635-42.
2000: Chaney A W; Pollack A; McNeese M D; Zagars G K; Pisters P W; Pollock R E; Hunt K K
Primary treatment of cystosarcoma phyllodes of the breast.
Cancer 2000;89(7):1502-11.
2000: Pollack A; Ashoori F; Sikes C; Joon D L; von Eschenbach A C; Zagars G K; Meistrich M L
The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions.
International journal of radiation oncology, biology, physics 2000;46(1):153-8.
1999: Khoo V S; Pollack A; Cowen D; Joon D L; Patel N; Terry N H; Zagars G K; von Eschenbach A C; Meistrich M L; Troncoso P
Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy.
The Prostate 1999;41(3):166-72.
1999: Fleming J B; Berman R S; Cheng S C; Chen N P; Hunt K K; Feig B W; Respondek P M; Yasko A W; Pollack A; Patel S R; Burgess M A; Papadopoulos N E; Plager C; Zagars G; Benjamin R S; Pollock R E; Pisters P W
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2772-80.
1999: Zagars G K; Pollack A; Smith L G
Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate.
International journal of radiation oncology, biology, physics 1999;44(4):809-19.
1999: Pollack A; Zagars G K; Rosen I I
Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity.
Seminars in oncology 1999;26(2):150-61.
1999: Liebross R H; Pollack A; Lankford S P; Zagars G K; von Eschenbach A C; Geara F B
Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy: an evaluation based on disease outcome.
Cancer 1999;85(7):1577-85.
1999: Ballo M T; Zagars G K; Pollack A; Pisters P W; Pollack R A
Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):158-67.
1999: Hanus M C; Zagars G K; Pollack A
Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablation.
International journal of radiation oncology, biology, physics 1999;43(2):379-83.
1998: Ballo M T; Zagars G K; Pollack A
Radiation therapy in the management of desmoid tumors.
International journal of radiation oncology, biology, physics 1998;42(5):1007-14.
1998: Antolak J A; Rosen I I; Childress C H; Zagars G K; Pollack A
Prostate target volume variations during a course of radiotherapy.
International journal of radiation oncology, biology, physics 1998;42(3):661-72.
1998: Pollack A; Zagars G K; Goswitz M S; Pollock R A; Feig B W; Pisters P W
Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation.
International journal of radiation oncology, biology, physics 1998;42(3):563-72.
1998: Zagars G K; Pollack A; Pettaway C A
Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.
International journal of radiation oncology, biology, physics 1998;42(3):517-23.
1998: Liebross R H; Pollack A; Lankford S P; von Eschenbach A C; Zagars G K
Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy.
Urology 1998;52(4):647-52.
1998: Nguyen L N; Pollack A; Zagars G K
Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire.
Urology 1998;51(6):991-7.
1998: Ballo M T; Zagars G K; Pisters P; Pollack A
The role of radiation therapy in the management of dermatofibrosarcoma protuberans.
International journal of radiation oncology, biology, physics 1998;40(4):823-7.
1998: Pollack A; Zagars G K
External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?
Urology 1998;51(2):258-64.
1998: Chaney A W; Pollack A; McNeese M D; Zagars G K
Adjuvant radiotherapy for phyllodes tumor of breast.
Radiation oncology investigations 1998;6(6):264-7.
1997: Pollack A; Zagars G K
External beam radiotherapy dose response of prostate cancer.
International journal of radiation oncology, biology, physics 1997;39(5):1011-8.
1997: Pollack A; Wu C S; Czerniak B; Zagars G K; Benedict W F; McDonnell T J
Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(10):1823-9.
1997: Pollack A; Czerniak B; Zagars G K; Hu S X; Wu C S; Dinney C P; Chyle V; Benedict W F
Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer.
International journal of radiation oncology, biology, physics 1997;39(3):687-95.
1997: Zagars G K; Pollack A
Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;44(3):213-21.
1997: Zagars G K; Pollack A
Serum testosterone levels after external beam radiation for clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 1997;39(1):85-9.
1997: Zagars G K; Pollack A; von Eschenbach A C
Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation.
Cancer 1997;80(4):764-75.
1997: Joon D L; Hasegawa M; Sikes C; Khoo V S; Terry N H; Zagars G K; Meistrich M L; Pollack A
Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.
International journal of radiation oncology, biology, physics 1997;38(5):1071-7.
1997: Pollack A; Joon D L; Wu C S; Sikes C; Hasegawa M; Terry N H; White R A; Zagars G K; Meistrich M L
Quiescence in R3327-G rat prostate tumors after androgen ablation.
Cancer research 1997;57(12):2493-500.
1997: Lankford S P; Pollack A; Zagars G K
Prostate-specific antigen cancer volume: a significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapy.
International journal of radiation oncology, biology, physics 1997;38(2):327-33.
1997: Pollack A; Troncoso P; Zagars G K; von Eschenbach A C; Mak A C; Wu C S; Terry N H
The significance of DNA-ploidy and S-phase fraction in node-positive (stage D1) prostate cancer treated with androgen ablation.
The Prostate 1997;31(1):21-8.
1997: Zagars G K; Pollack A; von Eschenbach A C
Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era.
Cancer 1997;79(7):1370-80.
1997: Zagars G K; Pollack A; von Eschenbach A C
Serum testosterone--a significant determinant of metastatic relapse for irradiated localized prostate cancer.
Urology 1997;49(3):327-34.
1997: Pollack A; Zagars G K; Cole C J; Dinney C P; Swanson D A; Grossman H B
Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapy.
International journal of radiation oncology, biology, physics 1997;37(1):41-9.
1996: Zagars G K; Goswitz M S; Pollack A
Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy.
International journal of radiation oncology, biology, physics 1996;36(2):311-9.
1996: Chyle V; Zagars G K; Wheeler J A; Wharton J T; Delclos L
Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.
International journal of radiation oncology, biology, physics 1996;35(5):891-905.
1996: Chyle V; Pollack A; Czerniak B; Stephens L C; Zagars G K; Terry N H; Meyn R E
Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer.
International journal of radiation oncology, biology, physics 1996;35(2):281-7.
1996: Pollack A; Lankford S; Zagars G K; Babaian R J
Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy.
Cancer 1996;77(8):1515-23.
1996: Wu C S; Pollack A; Czerniak B; Chyle V; Zagars G K; Dinney C P; Hu S X; Benedict W F
Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.
Urology 1996;47(3):305-10.
1996: Zagars G K; Mullen J R; Pollack A
Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy.
International journal of radiation oncology, biology, physics 1996;34(5):983-94.
1996: Pollack A; Zagars G K; Starkschall G; Childress C H; Kopplin S; Boyer A L; Rosen I I
Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity.
International journal of radiation oncology, biology, physics 1996;34(3):555-64.
1995: Pollack A; Zagars G K; Cole C J; Dinney C P; Swanson D A; Grossman H B
The relationship of local control to distant metastasis in muscle invasive bladder cancer.
The Journal of urology 1995;154(6):2059-63; discussion 2063-4.
1995: Lankford S P; Pollack A; Zagars G K
Radiotherapy for regionally localized hormone refractory prostate cancer.
International journal of radiation oncology, biology, physics 1995;33(4):907-12.
1995: Zagars G K; Pollack A; von Eschenbach A C
Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
International journal of radiation oncology, biology, physics 1995;33(1):23-35.
1995: Cole C J; Pollack A; Zagars G K; Dinney C P; Swanson D A; von Eschenbach A C
Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
International journal of radiation oncology, biology, physics 1995;32(2):331-40.
1995: Zagars G K; Pollack A; Kavadi V S; von Eschenbach A C
Prostate-specific antigen and radiation therapy for clinically localized prostate cancer.
International journal of radiation oncology, biology, physics 1995;32(2):293-306.
1995: Zagars G K; Kavadi V S; Pollack A; von Eschenbach A C; Sands M E
The source of pretreatment serum prostate-specific antigen in clinically localized prostate cancer--T, N, or M?
International journal of radiation oncology, biology, physics 1995;32(1):21-32.
1995: Pollack A; Zagars G K; Kopplin S
Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer.
International journal of radiation oncology, biology, physics 1995;32(1):13-20.
1995: Hall M C; Navone N M; Troncoso P; Pollack A; Zagars G K; von Eschenbach A C; Conti C J; Chung L W
Frequency and characterization of p53 mutations in clinically localized prostate cancer.
Urology 1995;45(3):470-5.
1995: Zagars G K; Pollack A
Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome.
Urology 1995;45(3):476-83.
1995: Pollack A; Zagars G K; Sands M E
Local treatment for prostate cancer: 90 years later--response to M. V. Pilepich.
International journal of radiation oncology, biology, physics 1995;31(2):436.
1995: Zagars G K; Ayala A G; von Eschenbach A C; Pollack A
The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy.
International journal of radiation oncology, biology, physics 1995;31(2):237-45.
1995: Sands M E; Pollack A; Zagars G K
Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation.
International journal of radiation oncology, biology, physics 1995;31(1):13-9.
1994: Hall M C; Troncoso P; Pollack A; Zhau H Y; Zagars G K; Chung L W; von Eschenbach A C
Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy.
Urology 1994;44(6):869-75.
1994: Pollack A; Zagars G K; Dinney C P; Swanson D A; von Eschenbach A C
Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.
Cancer 1994;74(10):2819-27.
1994: Pollack A; Zagars G K; el-Naggar A K; Terry N H
Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer.
Urology 1994;44(5):711-8.
1994: Zagars G K
Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
The Journal of urology 1994;152(5 Pt 2):1786-91.
1994: Mullen J R; Zagars G K
Synovial sarcoma outcome following conservation surgery and radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(1):23-30.
1994: Pollack A; Zagars G K; Swanson D A
Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors.
International journal of radiation oncology, biology, physics 1994;30(2):267-77.
1994: Geara F B; Zagars G K; Pollack A
Influence of initial presentation on treatment outcome of clinically localized prostate cancer treated by definitive radiation therapy.
International journal of radiation oncology, biology, physics 1994;30(2):331-7.
1994: Kavadi V S; Zagars G K; Pollack A
Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications.
International journal of radiation oncology, biology, physics 1994;30(2):279-87.
1994: Sands M E; Zagars G K; Pollack A; von Eschenbach A C
Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer.
Urology 1994;44(2):215-20.
1994: Pollack A; Zagars G K; Kavadi V S
Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer.
Cancer 1994;74(2):670-8.
1994: Zagars G K; Sands M E; Pollack A; von Eschenbach A C
Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcome.
The Journal of urology 1994;151(5):1330-3.
1994: Zagars G K; Geara F B; Pollack A; von Eschenbach A C
The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy.
Cancer 1994;73(7):1904-12.
1994: Pollack A; Zagars G K; el-Naggar A K; Gauwitz M D; Terry N H
Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
Cancer 1994;73(7):1895-903.
1994: Gauwitz M D; Pollack A; el-Naggar A K; Terry N H; von Eschenbach A C; Zagars G K
The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy.
International journal of radiation oncology, biology, physics 1994;28(4):821-8.
1994: Zagars G K; Pollack A
The serum prostate-specific antigen level three months after radiotherapy for prostate cancer: an early indicator of response to treatment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;30(2):121-7.
1993: Zagars G K
The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate.
International journal of radiation oncology, biology, physics 1993;27(1):39-45.
1993: Zagars G K; von Eschenbach A C; Ayala A G
Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
Cancer 1993;72(5):1709-25.
1993: Zagars G K; Pollack A
The fall and rise of prostate-specific antigen. Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer.
Cancer 1993;72(3):832-42.
1993: Zagars G K; von Eschenbach A C
Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy.
Cancer 1993;72(2):538-48.
1993: Wheeler J A; Zagars G K; Ayala A G
Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression.
Cancer 1993;71(11):3783-7.
1993: Dosmann M A; Zagars G K
Post-orchiectomy radiotherapy for stages I and II testicular seminoma.
International journal of radiation oncology, biology, physics 1993;26(3):381-90.
1993: Garden A S; Zagars G K; Delclos L
Primary carcinoma of the female urethra. Results of radiation therapy.
Cancer 1993;71(10):3102-8.
1992: Zagars G K
Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy.
International journal of radiation oncology, biology, physics 1992;23(1):47-53.
1992: Gauwitz M D; Zagars G K
Treatment of seminoma arising in cryptorchid testes.
International journal of radiation oncology, biology, physics 1992;24(1):153-9.
1991: Zagars G K; von Eschenbach A C; Ayala A G; Schultheiss T E; Sherman N E
The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy.
Cancer 1991;68(11):2370-7.
1991: Greskovich F J; Zagars G K; Sherman N E; Johnson D E
Complications following external beam radiation therapy for prostate cancer: an analysis of patients treated with and without staging pelvic lymphadenectomy.
The Journal of urology 1991;146(3):798-802.
1991: Zagars G K; Sherman N E; Babaian R J
Prostate-specific antigen and external beam radiation therapy in prostate cancer.
Cancer 1991;67(2):412-20.
1990: Carlton J C; Zagars G K; Oswald M J
The role of serum prostatic acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapy.
International journal of radiation oncology, biology, physics 1990;19(6):1383-8.
1990: Talbert M L; Zagars G K; Sherman N E; Romsdahl M M
Conservative surgery and radiation therapy for soft tissue sarcoma of the wrist, hand, ankle, and foot.
Cancer 1990;66(12):2482-91.
1990: Sherman N E; Romsdahl M; Evans H; Zagars G; Oswald M J
Desmoid tumors: a 20-year radiotherapy experience.
International journal of radiation oncology, biology, physics 1990;19(1):37-40.
1990: Swanson D A; Liles A; Zagars G K
Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder.
The Journal of urology 1990;143(1):37-40.
1988: Zagars G K; Johnson D E; von Eschenbach A C; Hussey D H
Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of a prospective randomized study.
International journal of radiation oncology, biology, physics 1988;14(6):1085-91.
1988: Babaian R J; Zagars G K
Testicular seminoma: the M. D. Anderson experience. An analysis of pathological and patient characteristics, and treatment recommendations.
The Journal of urology 1988;139(2):311-4.
1988: Zagars G K
Seminoma with bulky abdominal disease.
International journal of radiation oncology, biology, physics 1988;14(2):395-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Gunar Zagars

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Gunar Zagars (preview)

All Publications